A comparison of 2013 and 2022 data shows that cancer costs are not uniformly rising. Costs decreased for metastatic colorectal cancer but increased for both metastatic non–small cell lung cancer and multiple myeloma.
Troyen A. Brennan, MD, PhD
Advertisement
Articles by Troyen A. Brennan, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives
3
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
4
How ID, HIV Clinicians Can Influence Policy in an Election Year
5